Cargando…

Radio-induced malignancies after breast cancer postoperative radiotherapy in patients with Li-Fraumeni syndrome

BACKGROUND: There are no specific recommendations for the management of breast cancer patients with germ-line p53 mutations, an exceptional genetic condition, particularly regarding postoperative radiotherapy. Preclinical data suggested that p53 mutations conferred enhanced radiosensitivity in vitro...

Descripción completa

Detalles Bibliográficos
Autores principales:	Heymann, Steve, Delaloge, Suzette, Rahal, Arslane, Caron, Olivier, Frebourg, Thierry, Barreau, Lise, Pachet, Corinne, Mathieu, Marie-Christine, Marsiglia, Hugo, Bourgier, Céline
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2010
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2988810/ https://www.ncbi.nlm.nih.gov/pubmed/21059199 http://dx.doi.org/10.1186/1748-717X-5-104

Ejemplares similares

Guidelines for the Li–Fraumeni and heritable TP53-related cancer syndromes
por: Frebourg, Thierry, et al.
Publicado: (2020)

Li-Fraumeni Syndrome
por: Vogel, Wendy H.
Publicado: (2017)

Hematologic malignancies and Li–Fraumeni syndrome
por: Swaminathan, Mahesh, et al.
Publicado: (2019)

Higher toxicity with 42 Gy in 10 fractions as a total dose for 3D-conformal accelerated partial breast irradiation: results from a dose escalation phase II trial
por: Bourgier, Celine, et al.
Publicado: (2012)

The first documentation of Li-Fraumeni syndrome in Korea.
por: Bang, Y. J., et al.
Publicado: (1995)

Pediatric Case of Li–Fraumeni Syndrome in Honduras
por: Martínez-Beckerat, R., et al.
Publicado: (2021)

Inhibiting the Priming for Cancer in Li-Fraumeni Syndrome
por: Pantziarka, Pan, et al.
Publicado: (2022)

A Case of Li-Fraumeni Associated Thymoma
por: Sivayoganathan, Thibacg, et al.
Publicado: (2022)

Mixed modality treatment planning of accelerated partial breast irradiation: to improve complex dosimetry cases
por: El Nemr, Mohamed, et al.
Publicado: (2011)

Maxillary mesenchymal chondrosarcoma leading to a diagnosis of Li-Fraumeni syndrome
por: Ventura, Eduardo, et al.
Publicado: (2020)

Li-Fraumeni syndrome--a molecular and clinical review.
por: Varley, J. M., et al.
Publicado: (1997)

Li-Fraumeni Syndrome: A Rare Genetic Disorder
por: Tazin, Faria, et al.
Publicado: (2022)

Carbon ion radiotherapy eradicates medulloblastomas with chromothripsis in an orthotopic Li-Fraumeni patient-derived mouse model
por: Simovic, Milena, et al.
Publicado: (2021)

Li‐Fraumeni versus Pseudo‐Li‐Fraumeni Syndrome: Key Insights for Interpreting Next‐Generation Sequencing Reports in Patients with Suspected Cancer Predisposition Syndromes
por: Sorscher, Steven, et al.
Publicado: (2017)

Li-Fraumeni syndrome: a case report from Italy.
por: Orjuela, M., et al.
Publicado: (1990)

Li Fraumeni syndrome, cancer and senescence: a new hypothesis
por: Pantziarka, Pan
Publicado: (2013)

PEComa in a Young Patient with Known Li-Fraumeni Syndrome
por: Neofytou, Kyriakos, et al.
Publicado: (2015)

Primed for cancer: Li Fraumeni Syndrome and the pre-cancerous niche
por: Pantziarka, Pan
Publicado: (2015)

Prostate Cancer and Li-Fraumeni Syndrome: Implications for Screening and Therapy
por: Spees, Colleen K., et al.
Publicado: (2015)

The Features of Colorectal Tumors in a Patient with Li-Fraumeni Syndrome
por: Yoshida, Tsukasa, et al.
Publicado: (2017)

The contribution of CHEK2 to the TP53-negative Li-Fraumeni phenotype
por: Ruijs, Marielle WG, et al.
Publicado: (2009)

Regular surveillance for Li-fraumeni syndrome: advice, adherence and perceived benefits
por: Lammens, C. R. M., et al.
Publicado: (2010)

Genetic and functional analysis of a Li Fraumeni syndrome family in China
por: Hu, Huaying, et al.
Publicado: (2016)

Surveillance Screening in Li-Fraumeni Syndrome: Raising Awareness of False Positives
por: Kumar, Prerna, et al.
Publicado: (2018)

Difficulties of Management of Multiple Synchronous Bone Tumors in Li-Fraumeni Syndrome
por: Huby, Marine, et al.
Publicado: (2019)

Medical guidelines for Li–Fraumeni syndrome 2019, version 1.1
por: Kumamoto, Tadashi, et al.
Publicado: (2021)

Arsenic trioxide extends survival of Li–Fraumeni syndrome mimicking mouse
por: Li, Jiabing, et al.
Publicado: (2023)

Constitutional p53 mutation in a non-Li-Fraumeni cancer family.
por: Prosser, J., et al.
Publicado: (1992)

Chromosome instability is a predominant trait of fibroblasts from Li-Fraumeni families.
por: Boyle, J. M., et al.
Publicado: (1998)

The Benefit and Burden of Cancer Screening in Li-Fraumeni Syndrome: A Case Report
por: Jhaveri, Ami P., et al.
Publicado: (2015)

Does PTEN gene mutation play any role in Li-Fraumeni syndrome
por: Akouchekian, Mansoureh, et al.
Publicado: (2016)

Autism spectrum disorder and Li-Fraumeni syndrome: purely coincidental or mechanistically associated?
por: Kuhlen, Michaela, et al.
Publicado: (2017)

Mitochondrial stress delays tumorigenesis in a Li-Fraumeni syndrome mouse model
por: Donnelly, Matthew P., et al.
Publicado: (2019)

The first pancreatic neuroendocrine tumor in Li-Fraumeni syndrome: a case report
por: Aversa, John G., et al.
Publicado: (2020)

Multiple meningiomas arising within the same hemisphere associated with Li-Fraumeni syndrome
por: Hong, Christopher S., et al.
Publicado: (2021)

Correction to: Medical guidelines for Li–Fraumeni syndrome 2019, version 1.1
por: Kumamoto, Tadashi, et al.
Publicado: (2021)

Clinical and genetic characteristics of children with acute lymphoblastic leukemia and Li–Fraumeni syndrome
por: Winter, Greta, et al.
Publicado: (2021)

MEDB-14. Clinical outcome of pediatric medulloblastoma patients with Li-Fraumeni syndrome
por: Kolodziejczak, Anna, et al.
Publicado: (2022)

A case report: invasive ductal carcinoma in mosaic Li-Fraumeni syndrome
por: Wenger, Danielle, et al.
Publicado: (2022)

Pediatric high-grade glioma MYCN is frequently associated with Li-Fraumeni syndrome
por: Guerrini-Rousseau, Léa, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_cu6fd4m7e70upinpoggn7npod2